Our customers say Excellent
4.8 out of 5 based on 9701 reviews
  • CBD targets the symptoms of diabetes

    CBD targets the symptoms of diabetes
    Researchers are working on cannabinoids to combat both diabetes causes and symptoms. Maintaining a stable homeostatic environment in our body seems to be the key to novel cannabis treatment for diabetes. A cure is yet to come, but some symptoms can be mitigated with cannabis flowers and extracts.

    Diabetes is a set of metabolic diseases that are due to the inability of the body to regulate the amount of sugar, especially glucose, in the blood. Glucose levels are regulated by hormones like insulin, which are produced in the pancreas. Diabetes can cause long-term complications such as cardiovascular disease, stroke, kidney and eye damage.


    A growing body of research confirms the anecdotal evidence that is built among diabetic patients and shows that cannabis can have beneficial effects. THC and CBD anti-inflammatory action may help in arterial inflammation, which is common in diabetes, while the neuroprotective effect may reduce the inflammation of the nerves and the associated pain. Cannabinoids can also act as vasodilators, improve blood circulation and have an anti-convulsant effect on muscle spasms and gastrointestinal disorders. The typical diabetic restless syndrome could also be treated with cannabis to help patients better. Recent laboratory studies also show that the endocannabinoid system could actually aim to stabilize blood sugar levels and thus point to the heart of the disease. Unfortunately, this is laboratory research. There is no cannabis therapy today against diabetes conceivable.


    Although clinical research on human patients is lacking, laboratory experiments show a strict correlation between diabetes activity and cannabinoids. One of the first studies demonstrating the influence of the endocannabinoid system on diabetes was published in 2006 entitled "Cannabidiol reduces the incidence of diabetes in non-obese diabetic mice". This study indicated that CBD can inhibit and delay destructive insulitis and inflammatory cytokine production, resulting in a decreased incidence of diabetes.

    Researchers also wrote about a possible specific immunomodulatory mechanism that was activated by CBD. This hypothesis is confirmed by other findings on cannabidiol, the onset of autoimmune diabetes in mice arrested, and a study that discovered some neuroprotective effects of CBD in an experimental model of diabetes. Research also finds that CBD attenuates cardiac dysfunction in diabetic cardiomyopathic mice.

    A study entitled "Marijuana in the management of diabetes" was published in the American Journal of Medicine in 2013. In this review, past and current cannabis use has been associated with lower levels of fasting insulin, blood glucose and insulin resistance. According to this study, cannabis users are less likely to become obese, and have lower body mass index measurements. Cannabis smokers also had a higher level of "good cholesterol" and smaller waist circumference. An important finding of this research is that cannabis users have a better carbohydrate metabolism than non-users, the kind of confirmation of the laboratory test results that we have seen before.

    One of the most recent important studies dates back to 2015, when scientists led by Raphael Mechoulam, known for discovering CBD, have shown that the anti-inflammatory properties of cannabidiol are used to treat various diseases, including type 2 diabetes could. Finally, ** an October 2016 research showed that experimental CBD treatment reduces the markers of inflammation in the pancreatic microcirculation in mice. All of these studies conclude that cannabis compounds have a role in controlling blood sugar levels and in reducing pain or other symptoms of diabetes. We do not yet know how to turn these results into medicine.


    Outside the labs and in the homes of patients, there is plenty of evidence showing that cannabis is effective in the treatment of eye disease, chronic pain, sleep disorders and other diabetes-related disorders. The way people are treated for diabetes also depends on whether the person has additional complications and their overall health or not. Some patients supplement their cannabinoid therapies.
    Cannabis may initially boost appetite and over-nutrition, but in the long term it has the opposite effect and may even protect against obesity. Cannabis extracts with varying proportions between THC, CBD, other cannabinoids, and terpenes, or only non-psychotropic CBD may support cardiac and arterial health. The same hemp or cannabis extracts can be used to produce topical creams to relieve neuropathic pain. Conversely, there is a potential risk of cannabis use with diabetes hypoglycemia, as there are some concerns that glucose levels could go unnoticed